| Followers | 250 |
| Posts | 14020 |
| Boards Moderated | 3 |
| Alias Born | 07/07/2006 |
Friday, October 23, 2009 10:11:14 AM
EPCT volume spike
MKA said nice room, so will post here as well, varies a bit where i post, usually two or three rooms
just basic chart here
entry from oct 13th
Small niche drug ceplene, approved in europe, still looking for a partner
Azixa , IIb very promising cancer drug, trial run by MYRX, but they licended it from EPCT
azixa results due as well Q4 2009
also rumour on novartis interest
but mainly ceplene and licensed drug to myrx named azixa
basic chart, news driven here onwards
MKA said nice room, so will post here as well, varies a bit where i post, usually two or three rooms
just basic chart here
entry from oct 13th
Small niche drug ceplene, approved in europe, still looking for a partner
Azixa , IIb very promising cancer drug, trial run by MYRX, but they licended it from EPCT
azixa results due as well Q4 2009
also rumour on novartis interest
but mainly ceplene and licensed drug to myrx named azixa
basic chart, news driven here onwards
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
